Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s461771 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Wanjun Bai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China. Hauptthemen laut MEDLINE: Therapeutic Equivalency, Thalidomide, Fasting, Postprandial Period. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, People's Republic of China.
- Center for Clinical Pharmacology, Shanghai Innovstone Therapeutics Limited, Shanghai, People's Republic of China.
- Center for Clinical Pharmacology, CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd, Shijiazhuang, People's Republic of China.
ORCID-Profile: Wanjun Bai
Zitieren
APA
Bai, W., Sun, X., Qiu, B., Guo, C., Song, H., Hu, Y., Zhang, X., Yin, P., Wang, X., & Dong, Z. (2024). Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s461771
Vancouver
Bai W, Sun X, Qiu B, Guo C, Song H, Hu Y, et al. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s461771
BibTeX
@article{Bai2024,
author = {Bai, Wanjun and Sun, Xue and Qiu, Bo and Guo, Caihui and Song, Haojing and Hu, Yiting and Zhang, Xueyuan and Yin, Peihua and Wang, Xiaoru and Dong, Zhanjun},
title = {Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s461771}
}
EUVIMED